C1-inhibitor autoantibodies in SLE

Lupus

Volumn 19, Issue 5, 2010, Pages 634-638

  Meszaros T ^a   Fust G ^a   Farkas, H ^a   Jakab, L ^a   Temesszentandrasi G ^a   Nagy, G ^b   Kiss, E ^c   Gergely, P ^c   Zeher, M ^d   Griger, Z ^d   Czirjak L ^e   Hobor R ^e   Haris, A ^f   Polner, K ^f   Varga, L ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b Polyclinic of the Hospitaller Brothers of St John of God ^*  (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e UNIVERSITY OF PÉCS   (Hungary)

^f St Margit Hospital   (Hungary)

Author keywords

Anti C1 inhibitor; Anti C1q; Complement; Disease activity marker; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 77951226069     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309357059     Document Type: Article

References (20)

1. Walport MJ Complement. First of two parts. N Engl J Med 2001 ; 344: 1058-1066.
2. Sturfelt G., Truedsson L. Complement and its breakdown products in SLE. Rheumatology (Oxford) 2005 ; 44: 1227-1232. (Pubitemid 41487954)
3. Horvath L., Czirjak L., Fekete B., et al. High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 2001 ; 19: 667-672. (Pubitemid 34026830)
4. Uwatoko S., Aotsuka S., Okawa M., et al. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 1984 ; 30: 104-116. (Pubitemid 14219649)
5. Siegert C., Daha M., Westedt ML, van der Voort E., Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 1991 ; 18: 230-234.
6. Coremans IE, Spronk PE, Bootsma H., et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995 ; 26: 595-601.
7. Moroni G., Trendelenburg M., Del Papa N., et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001 ; 37: 490-498. (Pubitemid 32195287)
8. Jackson J., Sim RB, Whelan A., Feighery C. An IgG autoantibody which inactivates C1-inhibitor. Nature 1986 ; 323: 722-724. (Pubitemid 17172972)
9. Nakamura S., Yoshinari M., Saku Y., et al. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system. Ann Rheum Dis 1991 ; 50: 713-716.
10. Ochonisky S., Intrator L., Wechsler J., Revuz J., Bagot M. Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus. Dermatology 1993 ; 186: 261-263. (Pubitemid 23154543)
11. Ordi-Ros J., Paredes J., Detarsio G., Vilardell M. Autoantibodies to C1 inhibitor in patients with lupus disease. J Rheumatol 1997 ; 24: 1856-1858.
12. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 1725.
13. Bombardier C., Gladman DD, Urowitz MB, Caron D., Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 ; 35: 630-640.
14. Varga L., Szeplaki G., Visy B., et al. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naive patients. Mol Immunol 2007 ; 44: 1454-1460. (Pubitemid 44415947)
15. Siegert CE, Daha MR, Halma C., van der Voort EA, Breedveld FC IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin Exp Rheumatol 1992 ; 10: 19-23.
16. Siegert CE, Daha MR, Swaak AJ, van der Voort EA, Breedveld FC The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1993 ; 67: 204-209.
17. Kumar A., Gupta R., Varghese T., Pande RM, Singal VK, Garg OP Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus. Indian J Med Res 1999 ; 110: 190-193.
18. Mandle R., Baron C., Roux E., et al. Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor. J Immunol 1994 ; 152: 4680-4685. (Pubitemid 24134429)
19. Donaldson VH, Wagner CJ, Davis AE 3rd. An autoantibody to C1-inhibitor recognizes the reactive center of the inhibitor. J Lab Clin Med 1996 ; 127: 229-232. (Pubitemid 2626803)
20. He S., Tsang S., North J., Chohan N., Sim RB, Whaley K. Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency. J Immunol 1996 ; 156: 2009-2013. (Pubitemid 26069338)